Ultrasound for acute chest syndrome in sickle cell disease
Part of Blood & lymphatic, Genetic & congenital, Lungs & breathing clinical trials.
This study uses a bedside ultrasound to check for acute chest syndrome in children and young adults with sickle cell disease who are in the hospital. The goal is to see if this simple scan can help diagnose the condition early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 25 years old or younger.
- Must have sickle cell disease (any type).
- Currently in the hospital for a sickle cell complication, such as a pain crisis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding acupuncture to standard pain treatments can help manage pain in people with sickle cell disease. It involves brain scans, questionnaires, and acupuncture sessions to see if this approach reduces pain and improves quality of life.
This study uses a simple, safe ultrasound of the chest to look at the lungs and surrounding area during a sickle cell pain crisis. The goal is to see if this imaging can help detect early signs of a serious complication called acute chest syndrome, which could lead to faster treatment.
This study tests whether using lung ultrasound can help doctors quickly spot and treat acute chest syndrome in children with sickle cell disease. It may lead to faster, safer care for kids in the intensive care unit.
This study tests if using a bedside ultrasound (a quick, painless scan) of the chest and lungs can help doctors better understand and manage pain crises in people with sickle cell disease. If you are in the hospital for a severe pain crisis, you may be able to join.
This study uses a PET scan to look for links between abnormal heart “filling” problems and how well blood reaches the heart muscle in people with sickle cell disease. The results may help explain early heart changes in sickle cell and guide future care.
This trial tests a new treatment called CS-206 for adolescents with severe sickle cell disease. It aims to see if this treatment can help by making stem cell transplants safer and more effective for people who have not done well with standard care.
Hear when a new Acute Chest Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.